Search Results - "García‐García, Idrian"

Adjuvant interferon gamma in patients with drug - resistant pulmonary tuberculosis: a pilot study by Suárez-Méndez, Roberto, García-García, Idrian, Fernández-Olivera, Norma, Valdés-Quintana, Magalys, Milanés-Virelles, María T, Carbonell, Dalia, Machado-Molina, Delfina, Valenzuela-Silva, Carmen M, López-Saura, Pedro A

“…Tuberculosis (TB) is increasing in the world and drug-resistant (DR) disease beckons new treatments. To evaluate the action of interferon (IFN) gamma as…”
Get full text

Tratamiento de la alogenosis facial con Árnica montana L homeopatizada by Noriega Rodríguez, Daniel Rodolfo, Estévez Aparicio, Aramís, Oviedo Salazar, Roxana, García-García, Idrian, González-García, Sergio

“…Resumen Introducción. La alogenosis iatrogénica se debe a la aplicación de biopolímeros con fines estéticos, con una prevalencia en aumento y sin un…”
Get full text

Propiedades antimicrobianas de las preparaciones plaquetarias aplicadas sobre quemaduras by Montalvo Benítez, Odette Karina, Hernández González, Hernán, García García, Idrian

“…RESUMEN Introducción: Por sus propiedades, las preparaciones plaquetarias son útiles en el control del crecimiento bacteriano en la piel del quemado. Objetivo:…”
Get full text

Pharmacokinetic and pharmacodynamic characterization of a novel formulation containing co-formulated interferons alpha-2b and gamma in healthy male volunteers by García-García, Idrian, Hernández-González, Ignacio, Díaz-Machado, Alina, González-Delgado, Carlos A, Pérez-Rodríguez, Sonia, García-Vega, Yanelda, Campos-Mojena, Rosario, Tuero-Iglesias, Ángela D, Valenzuela-Silva, Carmen M, Cruz-Ramírez, Alieski, Martín-Trujillo, Alis, Santana-Milián, Héctor, López-Saura, Pedro A, Bello-Rivero, Iraldo

“…More potent antitumor activity is desired in Interferon (IFN)-treated cancer patients. This could be achieved by combining IFN alpha and IFN gamma. The aim of…”
Get full text

Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: a randomized, double-blind, placebo-controlled study by Milanés-Virelles, María T, García-García, Idrian, Santos-Herrera, Yamilet, Valdés-Quintana, Magalys, Valenzuela-Silva, Carmen M, Jiménez-Madrigal, Gaspar, Ramos-Gómez, Thelvia I, Bello-Rivero, Iraldo, Fernández-Olivera, Norma, Sánchez-de la Osa, Reinaldo B, Rodríguez-Acosta, Carmen, González-Méndez, Lidia, Martínez-Sánchez, Gregorio, López-Saura, Pedro A

“…High antibiotic resistance is described in atypical Mycobacteriosis, mainly by Mycobacterium avium complex (MAC). A randomized, double-blind,…”
Get full text

Clinical evaluation of patients with benign prostatic hyperplasia, treated with the natural product Calprost®: a randomized, controlled study by Magnelis Machado-Leiva, Daise Jiménez-Rodríguez, Tatiana Festary-Casanovas, Deydree C. Silveira-Pacheco, Emilio S. Barroso-de la Cruz, Mariela Suárez-Reyes, Genma Salas-Cruz, Haydee Wong-Arocha, Roberto Fernández-Viera, Ángela D. Tuero-Iglesias, René Delgado-Hernández, Idrian García-García, Calprost Study Group

“…Context: Benign Prostatic Hyperplasia (BPH) is a common disease that course with Lower Urinary Tract Symptoms (LUTS), mainly in over 50 years-old men. Commonly…”
Get full text

Pharmacokinetic and pharmacodynamic characterization of a new formulation containing synergistic proportions of interferons alpha-2b and gamma (HeberPAG) in patients with mycosis fungoides: an open-label trial by García-Vega, Yanelda, García-García, Idrian, Collazo-Caballero, Sonia E, Santely-Pravia, Egla E, Cruz-Ramírez, Alieski, Tuero-Iglesias, Angela D, Alfonso-Alvarado, Cristian, Cabrera-Placeres, Mileidys, Castro-Basart, Nailet, Duncan-Roberts, Yaquelín, Carballo-Treto, Tania I, Soto-Matos, Josanne, Izquierdo-Toledo, Yoandy, Vázquez-Blomquist, Dania, García-Iglesias, Elizeth, Bello-Rivero, Iraldo

“…The synergistic combination of interferon (IFN) alpha-2b and IFN gamma results in more potent in vitro biological effects mediated by both IFNs. The aim of…”
Get full text

Clinical evaluation of patients with benign prostatic hyperplasia, treated with the natural product Calprost®: a randomized, controlled study by Machado-Leiva, Magnelis, Jiménez-Rodríguez, Daise, Festary-Casanovas, Tatiana, Silveira-Pacheco, Deydree C., Barroso-de la Cruz, Emilio S., Suárez-Reyes, Mariela, Salas-Cruz, Genma, Wong-Arocha, Haydee, Fernández-Viera, Roberto, Tuero-Iglesias, Ángela D., Delgado-Hernández, René, García-García, Idrian

“…Context: Benign Prostatic Hyperplasia (BPH) is a common disease that course with Lower Urinary Tract Symptoms (LUTS), mainly in over 50 years-old men. Commonly…”
Get full text

Pharmacokinetic and pharmacodynamic comparison of two "pegylated" interferon alpha-2 formulations in healthy male volunteers: a randomized, crossover, double-blind study by García-García, Idrian, González-Delgado, Carlos A, Valenzuela-Silva, Carmen M, Díaz-Machado, Alina, Cruz-Díaz, Marisol, Nodarse-Cuní, Hugo, Pérez-Pérez, Orlando, Bermúdez-Badell, Cimara H, Ferrero-Bibilonia, Joel, Páez-Meireles, Rolando, Bello-Rivero, Iraldo, Castro-Odio, Fidel R, López-Saura, Pedro A

“…Interferon (IFN) alpha conjugation to polyethylene glycol (PEG) results in a better pharmacokinetic profile and efficacy. The aim of this study was to compare…”
Get full text

Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: a parallel, randomized, double blind study by Pérez-Oliva, Jorge F, Casanova-González, Martha, García-García, Idrian, Porrero-Martín, Pedro J, Valenzuela-Silva, Carmen M, Hernández-Montero, Tairí, Lagarde-Ampudia, Marcia, Casanova-Kutsareva, Yuri, Avila-Albuerne, Yisel, Vargas-Batista, Alicia, Bobillo-López, Hailen, Herrera-Valdés, Raúl, López-Saura, Pedro A

“…Recombinant human erythropoietin (EPO) is used for the treatment of last stage renal anemia. A new EPO preparation was obtained in Cuba in order to make this…”
Get full text

Tratamiento con eritropoyetina recombinante humana, hipertrofia ventricular izquierda y balance beneficio riesgo en la ERC-3b by Pérez-Oliva Díaz, Jorge F, Casanova González, Martha, Cuesta Panaco, Orosmán, Bencomo Rodríguez, Osniel, López Tórres, Beatriz, González, Claudio, Cruz Benítez, Liván, García García, Idrian, Tuero Iglesias, Ángela D, Valenzuela Silva, Carmen M, López Saura, Pedro A

“…Introducción: la anemia renal es frecuente en la enfermedad renal crónica avanzada (ERC 3b-4) y el tratamiento con eritropoyetina recombinante humana la mejora…”
Get full text

Interferón gamma recombinante como alternativa terapéutica en niños con artritis idiopática juvenil by Coto Hermosilla, Cecilia, García García, Idrian, Díaz Rojo, Gisou, Bello Rivero, Iraldo, Bermudez Badell, Cimara, Valera Puente, Gloria, Cantero Oceguera, Dolores, Hernández González, Víctor, Méndez Méndez, Melba, Gómez Conde, Santa, Nodarse Cuní, Hugo, López Saura, Pedro

“…INTRODUCCIÓN. La artritis idiopática juvenil (AIJ) es una enfermedad del colágeno caracterizada por sinovitis crónica y síntomas extraarticulares, de inicio…”
Get full text

Reporte de dos casos de linfadenitis supurada causada por bacilo de Calmette-Guerin tratados con interferón gamma recombinante by Abreu Suárez, Gladys, García García, Idrian, Fuentes Fernández, Gladys, Ramos Gómez, Thelvia I., Martínez Grau, Isabel, González Méndez, Lidia, López Saura, Pedro A.

“…La linfadenitis supurada es una complicación poco frecuente que sigue a la vacunación con bacilo de Calmette-Guerin. Se describen los casos de dos niños con…”
Get full text

Bioequivalence of two recombinant granulocyte colony-stimulating factor formulations in healthy male volunteers: BIOEQUIVALENCE OF TWO G-CSF FORMULATIONS by Hernández-Bernal, Francisco, García-García, Idrian, González-Delgado, Carlos A., Valenzuela-Silva, Carmen, Soto-Hernández, Ramón, Ducongé, Jorge, Cervantes-Llano, Majel, Blanco-Garcés, Elizabeth, Rodríguez, Víctor, García-Vega, Yanelda, Bello-Rivero, Iraldo, Olivera-Ruano, Lourdes, López-Saura, Pedro

Get full text

Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof‐of‐Principle Issues from a Randomized Controlled Study by Rodriguez‐Labrada, Roberto, Ortega‐Sanchez, Ricardo, Hernández Casaña, Patricia, Santos Morales, Orestes, Padrón‐Estupiñan, Maria del Carmen, Batista‐Nuñez, Maricela, Jiménez Rodríguez, Daise, Canales‐Ochoa, Nalia, Peña Acosta, Arnoy, Medrano Montero, Jacqueline, Labrada Aguilera, Pedro Enrique, Estupiñán Rodriguez, Annelie, Vazquez‐Mojena, Yaimee, Almaguer Gotay, Dennis, Aymed‐García, Judey, García‐García, Idrian, Torres Vega, Reydenis, Viada González, Carmen, Valenzuela Silva, Carmen M., Silva Ricardo, Yanelis, Columbié Ximelis, Jorge, Tribin Rivero, Kenia, Valle Cabrera, Roselin, García‐Rodriguez, Julio Cesar, Crombet Ramos, Tania, Amaro‐González, Daniel, Rodriguez‐Obaya, Teresita, Velázquez‐Pérez, Luis

“…Background Several pieces of evidence have shown the neurotrophic effect of erythropoietin (EPO) and its introduction in the therapeutic practice of…”
Get full text

Nueva formulación liofilizada sin albúmina de interferón alfa-2b en pacientes con condiloma acuminado by Collazo Caballero, Sonia, García García, Idrian, Infante Cristiá, Ena, Nodarse Cuní, Hugo, Dopico Toledo, Acela P, Alfonso-Trujillo, Israel

“…Introducción El condiloma acuminado es una enfermedad viral caracterizada por lesiones verrugosas anogenitales, en la cual los procedimientos terapéuticos…”
Get full text

Enfermedad granulomatosa crónica by Marsán Suárez, Vianed, del Valle Pérez, Lázaro O, Macías Abraham, Consuelo, Palma Salgado, Lourdes, García García, Idrián, Sánchez Segura, Miriam, Arce Hernández, Ada A, Villaescusa Blanco, Rinaldo

“…La enfermedad granulomatosa crónica (EGC) es una inmunodeficiencia primaria de la fagocitosis. Se presenta un paciente de 13 años de edad que a partir el mes…”
Get full text

ACTR-24. COMBINATION OF IFN’S PROLONGS THE SURVIVAL OF PATIENTS WITH HIGH GRADE GLIOMA AND IMPACT IN VITRO PROLIFERATION AND GENE EXPRESSION PATTERNS OF GENOMIC SUBTYPES by Bello-Rivero, Iraldo, Arocha-Garcia, Agustin, Dominguez-Pena, Rafael, Rios-Cabrera, Margarita, Rodriguez-Rodriguez, Lysy, Mora-Garcia, Norma, Garcia-Garcia, Idrian, Vazquez-Blomquist, Dania, Miranda-Navarrro, Jamilet, Leenstra, Sieger, Raices-Cruz, Ivette, Hernandez-Rodriguez, Reinier, Santana-Milian, Hector

Get full text

Phase I clinical trial of the (131)I-labeled anticarcinoembryonic antigen CIGB-M3 multivalent antibody fragment by González, Gilmara Pimentel, García, Idrian García, González, Joaquín González, Sánchez, Lincidio Pérez, Mirabal, Milagros Velasco, Marín, Carlos Calderón, Ruiz, Fausto L García, Iglesias, Elizeth Garcia, de Queralta, Rosalina López, Toirac, Ramón Ropero, Avila, Marta Ayala, Díaz, Adlín López, Saura, Pedro A López, Gavilondo, Jorge V, González, Juan P Oliva

“…Center for Genetic Engineering and Biotechnology (CIGB)-M3 is a trivalent recombinant single-chain Fv antibody fragment specific for carcinoembryonic antigen…”
Get more information

Pharmacokinetic study of Growth Hormone-Releasing Peptide 6 (GHRP-6) in nine male healthy volunteers by Cabrales, Ania, Gil, Jeovanis, Fernández, Eduardo, Valenzuela, Carmen, Hernández, Francisco, García, Idrián, Hernández, Ariadna, Besada, Vladimir, Reyes, Osvaldo, Padrón, Gabriel, Berlanga, Jorge, Guillén, Gerardo, González, Luis Javier

“…GHRP-6 is a growth hormone secretagogue that also enhances tissue viability in different organs. In the present work, we studied the pharmacokinetics of this…”
Get full text